Access cutting-edge diabetic peripheral neuropathy treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access diabetic peripheral neuropathy specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetic peripheral neuropathy treatment provided free
This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, compared to placebo. Participants will either get an active medicine or a "dummy" medicine (placebo). Which treatment participants get is decided by chance. In this study the active, investigational medicine is called CagriSema. Doctors cannot yet prescribe CagriSema. For each participant, the study will last for about 10 months.
Sponsor: Novo Nordisk A/S
Check if you qualify for this diabetic peripheral neuropathy clinical trial in St Louis, MO
If you're searching for diabetic peripheral neuropathy treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic peripheral neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.